WINDTREE THERAPEUTICS INC /DE/ Stock-Based Compensation
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Stock-Based Compensation of $17.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ share-based payment arrangement, expense for the quarter ending 2025-09-30 was $17.00K, a 80.23% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ share-based payment arrangement, expense for the quarter ending 2025-06-30 was $31.00K, a 68.04% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ share-based payment arrangement, expense for the quarter ending 2025-03-31 was $72.00K, a 71.31% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ share-based payment arrangement, expense for the quarter ending 2024-12-31 was $21.00K, a 93.14% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ share-based payment arrangement, expense for fiscal 2024 was $455.00K, a 64.40% decline from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ share-based payment arrangement, expense for fiscal 2023 was $1.28M, a 58.59% decline from fiscal 2022.
- WINDTREE THERAPEUTICS INC /DE/ share-based payment arrangement, expense for fiscal 2022 was $3.09M, a 57.36% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ share-based payment arrangement, expense for fiscal 2021 was $7.24M, a 27.34% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2025-09-30 | $17.00K 10-Q · filed 2025-11-19 | $48.00K derived: sum of 2 quarters · filed 2025-11-19 | $121.00K 10-Q · filed 2025-11-19 | $141.00K derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2025-06-30 | $31.00K 10-Q · filed 2025-08-19 | $104.00K 10-Q · filed 2025-08-19 | $124.00K derived: sum of 3 quarters · filed 2025-08-19 | $210.00K derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2025-03-31 | $72.00K 10-Q · filed 2025-05-15 | $93.00K derived: sum of 2 quarters · filed 2025-05-15 | $179.00K derived: sum of 3 quarters · filed 2025-11-19 | $276.00K derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $107.00K derived: sum of 2 quarters · filed 2025-11-19 | $204.00K derived: sum of 3 quarters · filed 2025-11-19 | $455.00K 10-K · filed 2025-04-15 | ||
| 2024-09-30 | $86.00K 10-Q · filed 2025-11-19 | $183.00K derived: sum of 2 quarters · filed 2025-11-19 | $434.00K 10-Q · filed 2025-11-19 | $740.00K derived: sum of 4 quarters · filed 2025-11-19 | ||
| 2024-06-30 | $97.00K 10-Q · filed 2025-08-19 | $348.00K 10-Q · filed 2025-08-19 | $654.00K derived: sum of 3 quarters · filed 2025-08-19 | $959.00K derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | $251.00K 10-Q · filed 2025-05-15 | $557.00K derived: sum of 2 quarters · filed 2025-05-15 | $862.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.24M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $611.00K derived: sum of 2 quarters · filed 2025-04-15 | $993.00K derived: sum of 3 quarters · filed 2025-04-15 | $1.28M 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $305.00K 10-Q · filed 2024-11-26 | $687.00K derived: sum of 2 quarters · filed 2024-11-26 | $972.00K 10-Q · filed 2024-11-26 | $1.76M derived: sum of 4 quarters · filed 2024-11-26 | ||
| 2023-06-30 | $382.00K 10-Q · filed 2024-08-19 | $667.00K 10-Q · filed 2024-08-19 | $1.46M derived: sum of 3 quarters · filed 2024-08-19 | $2.20M derived: sum of 4 quarters · filed 2024-08-19 | ||
| 2023-03-31 | $285.00K 10-Q · filed 2024-05-15 | $1.08M derived: sum of 2 quarters · filed 2024-05-15 | $1.82M derived: sum of 3 quarters · filed 2024-05-15 | $2.60M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $791.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $1.53M derived: sum of 2 quarters · filed 2024-04-16 | $2.32M derived: sum of 3 quarters · filed 2024-04-16 | $3.09M 10-K · filed 2024-04-16 | ||
| 2022-09-30 | $744.00K 10-Q · filed 2023-11-09 | $1.52M derived: sum of 2 quarters · filed 2023-11-09 | $2.29M 10-Q · filed 2023-11-09 | $3.92M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $781.00K 10-Q · filed 2023-08-07 | $1.55M 10-Q · filed 2023-08-07 | $3.17M derived: sum of 3 quarters · filed 2023-08-07 | $4.80M derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $770.00K 10-Q · filed 2023-05-15 | $2.39M derived: sum of 2 quarters · filed 2023-05-15 | $4.02M derived: sum of 3 quarters · filed 2023-05-15 | $5.57M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.25M derived: sum of 2 quarters · filed 2023-03-31 | $4.79M derived: sum of 3 quarters · filed 2023-03-31 | $7.24M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $1.63M 10-Q · filed 2022-11-14 | $3.17M derived: sum of 2 quarters · filed 2022-11-14 | $5.62M 10-Q · filed 2022-11-14 | $6.90M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.54M 10-Q · filed 2022-08-11 | $3.99M 10-Q · filed 2022-08-11 | $5.27M derived: sum of 3 quarters · filed 2022-08-11 | $6.42M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $2.44M 10-Q · filed 2022-05-05 | $3.72M derived: sum of 2 quarters · filed 2022-05-05 | $4.87M derived: sum of 3 quarters · filed 2022-05-05 | $6.44M derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.43M derived: sum of 2 quarters · filed 2022-03-31 | $4.00M derived: sum of 3 quarters · filed 2022-03-31 | $5.68M 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $1.15M 10-Q · filed 2021-11-10 | $2.71M derived: sum of 2 quarters · filed 2021-11-10 | $4.40M 10-Q · filed 2021-11-10 | $5.92M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $1.57M 10-Q · filed 2021-08-05 | $3.25M 10-Q · filed 2021-08-05 | $4.77M derived: sum of 3 quarters · filed 2021-08-05 | $6.71M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $1.69M 10-Q · filed 2021-05-13 | $3.20M derived: sum of 2 quarters · filed 2021-05-13 | $5.14M derived: sum of 3 quarters · filed 2021-05-13 | $6.88M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $3.45M derived: sum of 2 quarters · filed 2021-03-29 | $5.19M derived: sum of 3 quarters · filed 2021-03-29 | $6.72M 10-K · filed 2021-03-29 | ||
| 2019-09-30 | $1.94M 10-Q · filed 2020-11-16 | $3.68M derived: sum of 2 quarters · filed 2020-11-16 | $5.21M 10-Q · filed 2020-11-16 | $5.46M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $1.74M 10-Q · filed 2020-08-14 | $1.74M 10-Q · filed 2019-08-14 | $3.27M 10-Q · filed 2020-08-14 | $3.27M 10-Q · filed 2019-08-14 | $3.52M derived: sum of 3 quarters · filed 2020-08-14 | $3.67M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $1.53M 10-Q · filed 2020-05-13 | $1.78M derived: sum of 2 quarters · filed 2020-05-13 | $1.93M derived: sum of 3 quarters · filed 2020-05-13 | $2.07M derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | $252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $397.00K derived: sum of 2 quarters · filed 2020-04-03 | $537.00K derived: sum of 3 quarters · filed 2020-04-03 | $955.00K 10-K · filed 2020-04-03 | ||
| 2018-09-30 | $145.00K 10-Q · filed 2019-11-14 | $285.00K derived: sum of 2 quarters · filed 2019-11-14 | $703.00K 10-Q · filed 2019-11-14 | $1.53M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $140.00K 10-Q · filed 2019-08-14 | $558.00K 10-Q · filed 2019-08-14 | $1.39M derived: sum of 3 quarters · filed 2019-08-14 | $1.56M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $418.00K 10-Q · filed 2019-05-20 | $1.25M derived: sum of 2 quarters · filed 2019-05-20 | $1.43M derived: sum of 3 quarters · filed 2019-05-20 | $1.68M derived: sum of 4 quarters · filed 2019-05-20 | ||
| 2017-12-31 | $829.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-23 | $1.01M derived: sum of 2 quarters · filed 2019-04-23 | $1.26M derived: sum of 3 quarters · filed 2019-04-23 | $1.56M 10-K/A · filed 2019-04-23 | ||
| 2017-09-30 | $178.00K 10-Q · filed 2018-11-14 | $432.00K derived: sum of 2 quarters · filed 2018-11-14 | $732.00K 10-Q · filed 2018-11-14 | $1.03M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $254.00K 10-Q · filed 2018-08-14 | $554.00K 10-Q · filed 2018-08-14 | $851.00K derived: sum of 3 quarters · filed 2018-08-14 | $1.12M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-21 | $597.00K derived: sum of 2 quarters · filed 2018-05-21 | $870.00K derived: sum of 3 quarters · filed 2018-05-21 | $1.12M derived: sum of 4 quarters · filed 2018-05-21 | ||
| 2016-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $570.00K derived: sum of 2 quarters · filed 2018-04-17 | $820.00K derived: sum of 3 quarters · filed 2018-04-17 | $1.42M 10-K · filed 2018-04-17 | ||
| 2016-09-30 | $273.00K 10-Q · filed 2017-11-14 | $523.00K derived: sum of 2 quarters · filed 2017-11-14 | $1.13M 10-Q · filed 2017-11-14 | $1.47M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $250.00K 10-Q · filed 2017-08-21 | $853.00K 10-Q · filed 2017-08-21 | $1.20M derived: sum of 3 quarters · filed 2017-08-21 | $1.61M derived: sum of 4 quarters · filed 2017-08-21 | ||
| 2016-03-31 | $603.00K 10-Q · filed 2017-05-15 | $947.00K derived: sum of 2 quarters · filed 2017-05-15 | $1.36M derived: sum of 3 quarters · filed 2017-05-15 | $1.70M derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $344.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $762.00K derived: sum of 2 quarters · filed 2017-03-31 | $1.10M derived: sum of 3 quarters · filed 2017-03-31 | $1.70M 10-K · filed 2017-03-31 | ||
| 2015-09-30 | $418.00K 10-Q · filed 2016-11-14 | $753.00K derived: sum of 2 quarters · filed 2016-11-14 | $1.35M 10-Q · filed 2016-11-14 | $1.95M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $335.00K 10-Q · filed 2016-08-10 | $934.00K 10-Q · filed 2016-08-10 | $1.53M derived: sum of 3 quarters · filed 2016-08-10 | $2.39M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2015-03-31 | $599.00K 10-Q · filed 2016-05-12 | $1.20M derived: sum of 2 quarters · filed 2016-05-12 | $2.06M derived: sum of 3 quarters · filed 2016-05-12 | $2.84M derived: sum of 4 quarters · filed 2016-05-12 | ||
| 2014-12-31 | $599.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $1.46M derived: sum of 2 quarters · filed 2016-03-29 | $2.24M derived: sum of 3 quarters · filed 2016-03-29 | $2.94M 10-K · filed 2016-03-29 | ||
| 2014-09-30 | $857.00K 10-Q · filed 2015-11-05 | $1.64M derived: sum of 2 quarters · filed 2015-11-05 | $2.34M 10-Q · filed 2015-11-05 | $2.95M derived: sum of 4 quarters · filed 2015-11-05 | ||
| 2014-06-30 | $781.00K 10-Q · filed 2015-08-10 | $1.49M 10-Q · filed 2015-08-10 | $2.09M derived: sum of 3 quarters · filed 2015-08-10 | $2.73M derived: sum of 4 quarters · filed 2015-08-10 | ||
| 2014-03-31 | $703.00K 10-Q · filed 2015-05-11 | $1.31M derived: sum of 2 quarters · filed 2015-05-11 | $1.95M derived: sum of 3 quarters · filed 2015-05-11 | $2.56M derived: sum of 4 quarters · filed 2015-05-11 | ||
| 2013-12-31 | $606.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $1.25M derived: sum of 2 quarters · filed 2015-03-16 | $1.85M derived: sum of 3 quarters · filed 2015-03-16 | $2.21M 10-K · filed 2015-03-16 | ||
| 2013-09-30 | $641.00K 10-Q · filed 2014-11-07 | $1.25M derived: sum of 2 quarters · filed 2014-11-07 | $1.60M 10-Q · filed 2014-11-07 | $2.74M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-06-30 | $607.00K 10-Q · filed 2014-08-07 | $963.00K 10-Q · filed 2014-08-07 | $2.10M derived: sum of 3 quarters · filed 2015-03-16 | $2.57M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2013-03-31 | $356.00K 10-Q · filed 2014-05-12 | $1.49M derived: sum of 2 quarters · filed 2015-03-16 | $1.96M derived: sum of 3 quarters · filed 2015-03-16 | $2.37M derived: sum of 4 quarters · filed 2015-03-16 | ||
| 2012-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $1.61M derived: sum of 2 quarters · filed 2015-03-16 | $2.01M derived: sum of 3 quarters · filed 2015-03-16 | $2.41M 10-K · filed 2015-03-16 | ||
| 2012-09-30 | $474.00K 10-Q · filed 2013-11-12 | $880.00K derived: sum of 2 quarters · filed 2013-11-12 | $1.28M 10-Q · filed 2013-11-12 | $1.63M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-06-30 | $406.00K 10-Q · filed 2013-08-08 | $804.00K 10-Q · filed 2013-08-08 | $1.16M derived: sum of 3 quarters · filed 2014-03-17 | $1.31M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2012-03-31 | $398.00K 10-Q · filed 2013-05-07 | $753.00K derived: sum of 2 quarters · filed 2014-03-17 | $901.00K derived: sum of 3 quarters · filed 2014-03-17 | $1.08M derived: sum of 4 quarters · filed 2014-03-17 | ||
| 2011-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $503.00K derived: sum of 2 quarters · filed 2014-03-17 | $686.00K derived: sum of 3 quarters · filed 2014-03-17 | $867.00K 10-K · filed 2014-03-17 | ||
| 2011-09-30 | $148.00K 10-Q · filed 2012-11-14 | $331.00K derived: sum of 2 quarters · filed 2012-11-14 | $512.00K 10-Q · filed 2012-11-14 | |||
| 2011-06-30 | $183.00K 10-Q · filed 2012-08-14 | $364.00K 10-Q · filed 2012-08-14 | ||||
| 2010-12-31 | $1.41M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |